C-type lectin receptor signaling in schistosomiasis - Report - MDSpire

C-type lectin receptor signaling in schistosomiasis

  • By

  • Santoshi Chaudhary

  • Parisa Kalantari

  • May 28, 2026

  • 0 min

Share

Signaling Pathways of C-type Lectin Receptors in Schistosomiasis

Overview

This review discusses the role of C-type lectin receptors (CLRs) in schistosomiasis, highlighting their interaction with schistosome-derived glycans and the resulting immune modulation. Key CLRs are shown to influence various immune responses, including protective and pathogenic pathways.

Background

Schistosomiasis is a significant neglected tropical disease affecting over 250 million people globally, primarily due to immunopathology caused by schistosome eggs. Understanding the immune modulation by CLRs is crucial for developing effective interventions and treatments. The complexity of CLR interactions with schistosome glycans presents both challenges and opportunities for advancing schistosomiasis research.

Data Highlights

No numerical or trial data provided in the source material.

Key Findings

  • Schistosome glycans interact with CLRs, influencing immune responses.
  • Key CLRs include mannose receptor, DC-SIGN, MGL, MBL, Dectin-1, Dectin-2, and Mincle.
  • CLR signaling can promote protective Th2 immunity or drive pathogenic Th17 responses.
  • CLR-mediated signaling involves crosstalk with other pattern recognition receptors, particularly Toll-like receptors.
  • Understanding CLR specificity and context-dependent signaling is essential for addressing disease susceptibility.

Clinical Implications

The modulation of immune responses by CLRs in schistosomiasis suggests potential targets for therapeutic intervention. Further research into CLR interactions may enhance understanding of disease mechanisms and inform treatment strategies.

Conclusion

The review emphasizes the critical role of CLRs in schistosomiasis, highlighting their potential as targets for future research and therapeutic development.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Immunological and Pathological Roles of Siglecs: A Molecular Review
  2. The Journal of Infectious Diseases, 2022 -- C-C Motif Ligand 7 and C-C Motif Chemokine Receptor 3 Dysregulation in Patients With Scrub Typhus and Association With Mortality
  3. Infection, 2023 -- Guidelines for Screening, Diagnosis, and Management of Schistosomiasis in Non-Endemic Regions: Consensus Recommendations from the Italian Society of Tropical Medicine and Global Health and Collaborating Italian Medical Societies
  4. Frontiers in Immunology, 2026 -- Temporal transcriptional dynamics in cutaneous leishmaniasis reveal novel targets for therapeutic interventions in a dermal mouse model
  5. Schistosomiasis, WHO Fact Sheet, 2024
  6. Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis, Scientific Reports, 2025
  7. Major human schistosome species express different glycans with immunological and diagnostic implications, Nature Communications, 2026
  8. WHO Schistosomiasis Fact Sheet
  9. Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis | Scientific Reports
  10. Major human schistosome species express different glycans with immunological and diagnostic implications | Nature Communications

Original Source(s)

Related Content